{
    "organizations": [],
    "uuid": "359c5742c8593cc5951f443f06f7d603eb0cd212",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-pangen-biotech-receives-patent/brief-pangen-biotech-receives-patent-idUSL3N1S34GR",
    "ord_in_thread": 0,
    "title": "Pangen Biotech receives patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 26 (Reuters) - Pangen Biotech Inc :\n* Says it received patent on April 26, for antibodies cross-reactive to Human and Mouse Sema3A and Uses thereof\n* Patent number is 10-2016-0123233\nSource text in Korean : goo.gl/9Xu8wm\n (Beijing Headline News)\n ",
    "published": "2018-04-26T16:55:00.000+03:00",
    "crawled": "2018-04-27T16:29:33.026+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "pangen",
        "biotech",
        "inc",
        "say",
        "received",
        "patent",
        "april",
        "antibody",
        "human",
        "mouse",
        "sema3a",
        "us",
        "thereof",
        "patent",
        "number",
        "source",
        "text",
        "korean",
        "beijing",
        "headline",
        "news"
    ]
}